Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1618 1644 1647 1654 1693
This examiner grants 67% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18043554 | IMMUNOGLOBULIN E ANTIBODY COMPOSITIONS AND METHODS OF USE | Non-Final OA | The Regents of the University of California |
| 18040888 | METHODS OF TREATING MALIGNANT GLIOBLASTOMA | Final Rejection | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 18027993 | DISCOVERY AND USE OF IMMUNOGENIC PEPTIDES FOR THE TREATMENT AND PREVENTION OF CANCERS | Non-Final OA | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
| 18514761 | ENGINEERED NEMO AND USES THEREOF | Non-Final OA | TRUSTEES OF DARTMOUTH COLLEGE |
| 18260741 | OVARIAN CANCER VACCINE | Non-Final OA | Trustees of Dartmouth College |
| 18332457 | Fibroblast Activation ImmunoPET for Detection of Fibrosis Activity | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18318218 | CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS | Non-Final OA | Takeda Pharmaceutical Company Limited |
| 18575494 | ANTIBODY SPECIFIC FOR MESOTHELIN AND USES THEREOF | Non-Final OA | INNOBATION BIO CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy